Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, Pezzolo A.

Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25.

2.

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.

Veneziani I, Brandetti E, Ognibene M, Pezzolo A, Pistoia V, Cifaldi L.

J Immunol Res. 2018 Apr 1;2018:4972410. doi: 10.1155/2018/4972410. eCollection 2018.

3.

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.

Bocca P, Di Carlo E, Caruana I, Emionite L, Cilli M, De Angelis B, Quintarelli C, Pezzolo A, Raffaghello L, Morandi F, Locatelli F, Pistoia V, Prigione I.

Oncoimmunology. 2017 Oct 4;7(1):e1378843. doi: 10.1080/2162402X.2017.1378843. eCollection 2017.

PMID:
29296542
4.

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.

Brandetti E, Veneziani I, Melaiu O, Pezzolo A, Castellano A, Boldrini R, Ferretti E, Fruci D, Moretta L, Pistoia V, Locatelli F, Cifaldi L.

Oncoimmunology. 2017 Apr 20;6(6):e1316439. doi: 10.1080/2162402X.2017.1316439. eCollection 2017.

5.

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Pezzolo A, Sementa AR, Lerone M, Morini M, Ognibene M, Defferrari R, Mazzocco K, Conte M, Gigliotti AR, Garaventa A, Pistoia V, Varesio L.

Cancer Biol Ther. 2017 May 4;18(5):285-289. doi: 10.1080/15384047.2017.1312231. Epub 2017 Apr 12.

6.

A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.

Dvorkina M, Nieddu V, Chakelam S, Pezzolo A, Cantilena S, Leite AP, Chayka O, Regad T, Pistorio A, Sementa AR, Virasami A, Barton J, Montano X, Lechertier T, Brindle N, Morgenstern D, Lebras M, Burns AJ, Saunders NJ, Hodivala-Dilke K, Bagella L, De The H, Anderson J, Sebire N, Pistoia V, Sala A, Salomoni P.

Clin Cancer Res. 2016 Jul 1;22(13):3398-409. doi: 10.1158/1078-0432.CCR-15-2081. Epub 2016 Apr 13. Erratum in: Clin Cancer Res. 2017 Feb 1;23 (3):870.

7.

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy.

Pistoia V, Pezzolo A.

J Immunol Res. 2016;2016:3142365. doi: 10.1155/2016/3142365. Epub 2016 Jan 27. Review.

8.

Isolation and characterization of renal cancer stem cells from patient-derived xenografts.

Hasmim M, Bruno S, Azzi S, Gallerne C, Michel JG, Chiabotto G, Lecoz V, Romei C, Spaggiari GM, Pezzolo A, Pistoia V, Angevin E, Gad S, Ferlicot S, Messai Y, Kieda C, Clay D, Sabatini F, Escudier B, Camussi G, Eid P, Azzarone B, Chouaib S.

Oncotarget. 2016 Mar 29;7(13):15507-24. doi: 10.18632/oncotarget.6266.

9.

Intratumoral diversity of telomere length in individual neuroblastoma tumors.

Pezzolo A, Pistorio A, Gambini C, Haupt R, Ferraro M, Erminio G, De Bernardi B, Garaventa A, Pistoia V.

Oncotarget. 2015 Apr 10;6(10):7493-503.

10.

Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.

Pezzolo A, Marimpietri D, Raffaghello L, Cocco C, Pistorio A, Gambini C, Cilli M, Horenstein A, Malavasi F, Pistoia V.

Oncotarget. 2014 Nov 15;5(21):10368-81.

11.

Telomere shortening and increased oxidative stress are restricted to venous tissue in patients with varicose veins: A merely local disease?

Palmieri D, Cafueri G, Mongelli F, Pezzolo A, Pistoia V, Palombo D.

Vasc Med. 2014 Apr;19(2):125-130. Epub 2014 Feb 20.

PMID:
24557807
12.

Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.

Marimpietri D, Petretto A, Raffaghello L, Pezzolo A, Gagliani C, Tacchetti C, Mauri P, Melioli G, Pistoia V.

PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.

13.

Immunosuppressive microenvironment in neuroblastoma.

Pistoia V, Morandi F, Bianchi G, Pezzolo A, Prigione I, Raffaghello L.

Front Oncol. 2013 Jun 26;3:167. doi: 10.3389/fonc.2013.00167. eCollection 2013.

14.

MYCN: from oncoprotein to tumor-associated antigen.

Pistoia V, Morandi F, Pezzolo A, Raffaghello L, Prigione I.

Front Oncol. 2012 Nov 16;2:174. doi: 10.3389/fonc.2012.00174. eCollection 2012.

15.

Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition.

Cafueri G, Parodi F, Pistorio A, Bertolotto M, Ventura F, Gambini C, Bianco P, Dallegri F, Pistoia V, Pezzolo A, Palombo D.

PLoS One. 2012;7(4):e35312. doi: 10.1371/journal.pone.0035312. Epub 2012 Apr 13.

16.

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

Cantilena S, Pastorino F, Pezzolo A, Chayka O, Pistoia V, Ponzoni M, Sala A.

Oncotarget. 2011 Dec;2(12):976-83.

17.

Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair.

Resaz R, Emionite L, Vanni C, Astigiano S, Puppo M, Lavieri R, Segalerba D, Pezzolo A, Bosco MC, Oberto A, Eva C, Chou JY, Varesio L, Barbieri O, Eva A.

J Hepatol. 2011 Dec;55(6):1263-71. doi: 10.1016/j.jhep.2011.02.033. Epub 2011 Apr 13.

PMID:
21703205
18.

Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

Pezzolo A, Coco S, Raso A, Parodi F, Pistorio A, Valdora F, Capra V, Zollo M, Aschero S, Basso E, Cama A, Nozza P, Gambini C, Cinalli G, Garrè ML, Iolascon A, Pistoia V, Tonini GP.

Cancer Lett. 2011 Sep 28;308(2):215-24. doi: 10.1016/j.canlet.2011.05.006. Epub 2011 Jun 8.

PMID:
21652146
19.

Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.

Pezzolo A, Parodi F, Marimpietri D, Raffaghello L, Cocco C, Pistorio A, Mosconi M, Gambini C, Cilli M, Deaglio S, Malavasi F, Pistoia V.

Cell Res. 2011 Oct;21(10):1470-86. doi: 10.1038/cr.2011.38. Epub 2011 Mar 15.

20.

Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.

Parodi F, Passoni L, Massimo L, Luksch R, Gambini C, Rossi E, Zuffardi O, Pistoia V, Pezzolo A.

OMICS. 2011 Mar;15(3):113-21. doi: 10.1089/omi.2010.0085. Epub 2011 Feb 14. Review.

PMID:
21319993
21.

Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway.

Petecchia L, Sabatini F, Varesio L, Camoirano A, Usai C, Pezzolo A, Rossi GA.

Chest. 2009 Jun;135(6):1502-1512. doi: 10.1378/chest.08-1780. Epub 2009 May 15.

PMID:
19447922
22.

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.

Pagnan G, Di Paolo D, Carosio R, Pastorino F, Marimpietri D, Brignole C, Pezzolo A, Loi M, Galietta LJ, Piccardi F, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M.

Clin Cancer Res. 2009 Feb 15;15(4):1199-209. doi: 10.1158/1078-0432.CCR-08-2477.

23.

Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.

Pezzolo A, Rossi E, Gimelli S, Parodi F, Negri F, Conte M, Pistorio A, Sementa A, Pistoia V, Zuffardi O, Gambini C.

Neuro Oncol. 2009 Apr;11(2):192-200. doi: 10.1215/15228517-2008-086. Epub 2008 Oct 15.

24.

Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.

Pezzolo A, Capra V, Raso A, Morandi F, Parodi F, Gambini C, Nozza P, Giangaspero F, Cama A, Pistoia V, Garrè ML.

Cancer Lett. 2008 Mar 18;261(2):235-43. doi: 10.1016/j.canlet.2007.11.021. Epub 2008 Jan 7.

PMID:
18179864
25.

Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide.

Boero S, Sabatini F, Silvestri M, Petecchia L, Nachira A, Pezzolo A, Scarso L, Rossi GA.

Immunol Lett. 2007 Sep 15;112(1):39-46. Epub 2007 Aug 1.

PMID:
17707916
26.

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.

Marimpietri D, Brignole C, Nico B, Pastorino F, Pezzolo A, Piccardi F, Cilli M, Di Paolo D, Pagnan G, Longo L, Perri P, Ribatti D, Ponzoni M.

Clin Cancer Res. 2007 Jul 1;13(13):3977-88.

27.

Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice.

Castriconi R, Dondero A, Cilli M, Ognio E, Pezzolo A, De Giovanni B, Gambini C, Pistoia V, Moretta L, Moretta A, Corrias MV.

Cancer Immunol Immunother. 2007 Nov;56(11):1733-42. Epub 2007 Apr 11.

PMID:
17426969
28.

Tumor origin of endothelial cells in human neuroblastoma.

Pezzolo A, Parodi F, Corrias MV, Cinti R, Gambini C, Pistoia V.

J Clin Oncol. 2007 Feb 1;25(4):376-83.

PMID:
17264333
29.

Chromosomal imbalances in pediatric Burkitt-like lymphoma and review of the literature in relation to other germinal center derived B-cell tumors.

Pezzolo A, Cinti R, Negri F, Parodi F, Garaventa A, Gambini C, Pistoia V.

Leuk Lymphoma. 2006 Nov;47(11):2359-64.

PMID:
17107910
30.

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A, Strada P, Ravetti JL, Pistoia V, Falanga A, Bacigalupo A.

Autoimmunity. 2006 Sep;39(6):505-11.

PMID:
17060030
31.

Genetic abnormalities and CNS tumors: report of two cases of ependymoma associated with Klinefelter's Syndrome (KS).

Garrè ML, Capra V, Di Battista E, Giampietri L, Nozza P, Raso A, Pezzolo A, Rossi A, Milanaccio C, Pavanello M, Naselli A.

Childs Nerv Syst. 2007 Feb;23(2):219-23. Epub 2006 Oct 13.

PMID:
17058088
32.

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.

Pastorino F, Brignole C, Di Paolo D, Nico B, Pezzolo A, Marimpietri D, Pagnan G, Piccardi F, Cilli M, Longhi R, Ribatti D, Corti A, Allen TM, Ponzoni M.

Cancer Res. 2006 Oct 15;66(20):10073-82.

33.

Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.

Brignole C, Marimpietri D, Pastorino F, Nico B, Di Paolo D, Cioni M, Piccardi F, Cilli M, Pezzolo A, Corrias MV, Pistoia V, Ribatti D, Pagnan G, Ponzoni M.

J Natl Cancer Inst. 2006 Aug 16;98(16):1142-57.

PMID:
16912267
34.

Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.

Ribatti D, Nico B, Pezzolo A, Vacca A, Meazza R, Cinti R, Carlini B, Parodi F, Pistoia V, Corrias MV.

Br J Cancer. 2006 Jun 19;94(12):1845-52. Epub 2006 May 23.

35.

Rhabdoid meningioma of the tentorium with expression of desmin in a 12-year-old Turner syndrome patient.

Nozza P, Raso A, Rossi A, Milanaccio C, Pezzolo A, Capra V, Gambini C, Pietsch T.

Acta Neuropathol. 2005 Aug;110(2):205-6. Epub 2005 Jul 16. No abstract available.

PMID:
16025286
36.

Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.

Puppo M, Pastorino S, Melillo G, Pezzolo A, Varesio L, Bosco MC.

Clin Cancer Res. 2004 Dec 15;10(24):8704-19.

37.

The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.

Airoldi I, Di Carlo E, Banelli B, Moserle L, Cocco C, Pezzolo A, Sorrentino C, Rossi E, Romani M, Amadori A, Pistoia V.

J Clin Invest. 2004 Jun;113(11):1651-9. Retraction in: J Clin Invest. 2014 Jun;124(6):2807.

38.

A novel case of immunodeficiency, centromeric instability, and facial anomalies (the ICF syndrome): immunologic and cytogenetic studies.

Pezzolo A, Prigione I, Chiesa S, Castellano E, Gimelli G, Pistoia V.

Haematologica. 2002 Mar;87(3):329-31.

39.

T-cell apoptosis in ICF syndrome.

Pezzolo A, Prigione I, Facchetti P, Castellano E, Viale M, Gimelli G, Pistoia V.

J Allergy Clin Immunol. 2001 Aug;108(2):310-2. No abstract available.

PMID:
11496256
40.

Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma.

Fais F, Fronza G, Roncella S, Inga A, Campomenosi P, Cutrona G, Pezzolo A, Fedeli F, Abbondandolo A, Chiorazzi N, Pistoia V, Ferrarini M.

Int J Cancer. 2000 Dec 1;88(5):744-50.

41.

Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient.

Roncella S, Cutrona G, Truini M, Airoldi I, Pezzolo A, Valetto A, Di Martino D, Dadati P, De Rossi A, Ulivi M, Fontana I, Nocera A, Valente U, Ferrarini M, Pistoia V.

Haematologica. 2000 Mar;85(3):256-62.

42.

[Prenatal diagnosis of triploidy and trisomy 21 through fetal erythroblasts isolated from maternal blood].

Pezzolo A, Santi F, Pistoia V, De Biasio P.

Minerva Med. 1997 Oct;88(10):393-9. Italian.

PMID:
9417534
43.

Prenatal diagnosis of triploidy using fetal cells in the maternal circulation.

Pezzolo A, Santi F, Pistoia V, De Biasio P.

Prenat Diagn. 1997 Apr;17(4):389. No abstract available.

PMID:
9160394
44.

The phenotype of a 45,X male with a Y/18 translocation.

Gimelli G, Cinti R, Varone P, Naselli A, Di Battista E, Pezzolo A.

Clin Genet. 1996 Jan;49(1):37-41.

PMID:
8721570
45.

Genotypic, phenotypic and biological characterization of a novel human lung adenocarcinoma cell line (LC 89)

Paganuzzi M, Marroni P, Pezzolo A, Gimelli G, Cavallo F, Di Pierro F, De Angelis P, Forni G, Grossi CE.

Oncology. 1994 May-Jun;51(3):220-3. Erratum in: Oncology 1994 Jul-Aug;51(4):379.

PMID:
8196904
46.

Definitive assignment of the growth hormone-releasing factor gene to 20q11.2.

Pezzolo A, Gimelli G, Sposito M, Giussani U, Rossi E, Zuffardi O.

Hum Genet. 1994 Feb;93(2):213-4.

PMID:
8112752
47.

Maternal derivation of inv dup (22) and clinical variation in cat-eye syndrome.

Tupler R, Hoeller A, Pezzolo A, Maraschio P.

Ann Genet. 1994;37(3):153-5.

PMID:
7847799
48.

Cytogenetics of multiple endocrine neoplasia syndromes. III. Analysis of an insulinoma from a subject with MEN 1 by chromosome painting.

Maraschio P, Pezzolo A, Brandi ML, Cortinovis M, Dainotti E, Scappaticci S, Fraccaro M.

Cancer Genet Cytogenet. 1993 Oct 1;70(1):68-70.

PMID:
8106142
49.

Presence of telomeric and subtelomeric sequences at the fusion points of ring chromosomes indicates that the ring syndrome is caused by ring instability.

Pezzolo A, Gimelli G, Cohen A, Lavaggetto A, Romano C, Fogu G, Zuffardi O.

Hum Genet. 1993 Aug;92(1):23-7.

PMID:
8365723
50.

ICF syndrome with variable expression in sibs.

Gimelli G, Varone P, Pezzolo A, Lerone M, Pistoia V.

J Med Genet. 1993 May;30(5):429-32.

Supplemental Content

Loading ...
Support Center